Table 2.
Univariate and multivariate analyses of various prognostic parameters in patients with CRC Cox regression analysis
Variable | Univariate analysis
|
Multivariate analysis
|
|||
---|---|---|---|---|---|
OS months (mean ± SD) | P-value | HR | P-value | 95% CI | |
Gender | 0.111 | ||||
Male | 50.155±2.589 | ||||
Female | 58.145±2.901 | ||||
Age, years | 0.515 | ||||
<60 | 51.270±4.648 | ||||
≥60 | 56.730±3.099 | ||||
Location | 0.882 | ||||
Colon | 56.830±1.036 | ||||
Rectum | 51.270±5.251 | ||||
Tumor size, cm | 0.983 | ||||
<5 | 56.730±0.826 | ||||
≥5 | 51.270±6.930 | ||||
TNM stage | <0.000** | ||||
I + II | 66.571±1.492 | Reference | |||
III + IV | 42.189±2.669 | 2.984 | 0.011* | 1.288–6.912 | |
T stage | 0.027* | ||||
T1, T2 | 64.946±1.981 | ||||
T3, T4 | 48.965±2.271 | ||||
N stage | <0.000** | ||||
N0 | 64.107±1.556 | Reference | |||
N1 + N2 | 38.586±3.037 | 2.059 | 0.062 | 0.965–4.394 | |
M stage | <0.000** | ||||
M0 | 57.126±1.835 | ||||
M1 | 20.302±7.558 | ||||
Differentiation | 0.323 | ||||
Well/moderately | 57.005±2.031 | ||||
Poorly | 44.402±5.075 | ||||
SRPK1 expression | 0.001* | ||||
Low | 62.248±1.788 | Reference | |||
High | 45.101±2.901 | 1.914 | 0.031* | 1.061–3.453 |
Note:
P<0.05,
P<0.001.
Abbreviations: CRC, colorectal cancer; OS, overall survival; SRPK1, serine/arginine protein kinase 1; TNM, tumor node metastasis.